Re: Sarah's reply to my email
|
7
|
Resverlogix Corp.
|
Jan 31, 2019 09:27PM
|
Re: The chart set up looks awesome imo....
|
7
|
Resverlogix Corp.
|
Dec 03, 2019 02:53PM
|
Re: One week later....
|
7
|
Resverlogix Corp.
|
May 21, 2021 10:05AM
|
Re: Resverlogix Announces Change in Fiscal Year-End to December 31
|
7
|
Resverlogix Corp.
|
Mar 14, 2021 07:08PM
|
Re: Statistical Significance
|
7
|
Resverlogix Corp.
|
Apr 13, 2019 10:56AM
|
Re: RVX Announces Update Webcast and Conference Call
|
6
|
Resverlogix Corp.
|
Jan 18, 2021 01:52PM
|
Re: Debt and 28 August
|
6
|
Resverlogix Corp.
|
Jul 28, 2017 09:40AM
|
Re: Some history
|
6
|
Resverlogix Corp.
|
Jan 25, 2023 09:23AM
|
Re: Sneaking Suspicion...
|
6
|
Resverlogix Corp.
|
Feb 05, 2021 08:05AM
|
Re: Forward looking statements...
|
6
|
Resverlogix Corp.
|
Feb 05, 2021 10:33AM
|
Re: IR
|
6
|
Resverlogix Corp.
|
Jan 10, 2023 10:54PM
|
Re: Irrational exuberance
|
6
|
Resverlogix Corp.
|
Sep 17, 2020 06:58PM
|
Re: Sneaking Suspicion...
|
6
|
Resverlogix Corp.
|
Feb 04, 2021 01:25PM
|
Data Safety Monitoring Board Udpate
|
6
|
Resverlogix Corp.
|
Dec 05, 2016 12:21PM
|
Resverlogix Announces Publication in High-impact, Peer-reviewed Journal, Clinical Epigenetics
|
6
|
Resverlogix Corp.
|
Nov 12, 2020 08:05AM
|
Resverlogix Announces Conversion of US$12 Million Debenture Strengthening Balance Sheet
|
6
|
Resverlogix Corp.
|
Oct 14, 2020 07:35AM
|
Resverlogix Randomizes First Patient in Taiwan/China Portion of the Phase 3 BETonMACE Clinical Trial
|
6
|
Resverlogix Corp.
|
Jul 10, 2017 07:53AM
|
Re: Warning: Long - Thoughts on Management
|
6
|
Resverlogix Corp.
|
Mar 25, 2021 06:36PM
|
Re: Latest on COVID-19
|
6
|
Resverlogix Corp.
|
Sep 28, 2022 12:49PM
|
Re: Resverlogix Announces Publication in High-impact, Peer-reviewed Journal, Clinical Epigenetics
|
6
|
Resverlogix Corp.
|
Nov 12, 2020 09:59AM
|